Showing results (1901-1910 of 2,028) with videos related to

Sort By:
Pageof 203
The Review of Scientific Instruments|August 3, 2015
Invited Article: First flight in space of a wide-field-of-view soft x-ray imager using lobster-eye optics: Instrument description and initial flight resultsMichael R Collier, F Scott Porter, David G Sibeck, et al.
Longitudinal and Life Course Studies : International Journal|August 3, 2022
Recruitment and retention of participants in longitudinal studies after a natural disasterGeraldine F H McLeod, L John Horwood, Brian A Darlow, et al.
Molecular Ecology|November 25, 2003
Phylogeography of the fungal pathogen Histoplasma capsulatumTakao Kasuga, Thomas J White, Gina Koenig, et al.
The Journal of Pediatrics|April 29, 2015
Predictors of Enteral Autonomy in Children with Intestinal Failure: A Multicenter Cohort StudyFaraz A Khan, Robert H Squires, Heather J Litman, et al.
Critical Care Medicine|April 19, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized TrialElliott Bennett-Guerrero, Jamie L Romeiser, Lillian R Talbot, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 21, 2021
Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma RegistryEve Denton, David B Price, Trung N Tran, et al.
Brain : a Journal of Neurology|May 5, 2023
Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1Curtis A Nutter, Benjamin M Kidd, Helmut A Carter, et al.
Scientific Reports|March 1, 2024
Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockadeS K Daniel, K M Sullivan, L K Dickerson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancerC A Carter, A Rajan, C Keen, et al.
Expert Opinion on Investigational Drugs|December 10, 2016
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trialsBryan Oronsky, Ramasamy Paulmurugan, Kira Foygel, et al.
Pageof 203